In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

SAN JOSE, Calif., Jan. 21, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer ...

On 98% of research and impact from the School of Biosciences is rated as world-leading or internationally excellent. Research Excellence Framework, 2021 Some of the projects below come with specific ...

OpenAI teamed up with Retro Biosciences to build a machine learning model focused on generating new proteins. The new model, called GPT-4b, is a custom version of OpenAI’s GPT-4o model built ...

Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in an attempt to re-introduce extinct animals, hopes to bring that tusked beast back in the world by late 2028.

After hours: February 10 at 5:14:33 PM EST Loading Chart for DTIL ...

The protein engineering project started a year ago when Retro Biosciences, a longevity research company based in San Francisco, approached OpenAI about working together. That link-up did not ...

We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...

The age of de-extinction may soon be a reality. Advances in genetic engineering and synthetic biology are making resurrecting animals once lost to this world a tangible prospect. The organizations ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. The age of de ...